Effective October 9th, 2025, Aqurance has been acquired by EY and will now be known as EY Aqurance. This strategic move enables us to deliver broader, stronger support for life sciences companies. Stay tuned for more updates as we embark on this new journey!

Tag: R&D

DIGITAL TRANSFORMATION ACCELERATOR

Digital accelerator

Overcoming Digital Transformation Roadblocks: A Pharma-Specific Approach to Success Many digital transformation initiatives fail—not because of technology, but due to misalignment between strategy, leadership, and execution. Weak business cases, disengaged leadership, and fragmented processes often derail progress before real value is realized. Our Digital Transformation Accelerator is designed to eliminate these roadblocks. With a focus […]